Insmed, Inc. (INSM)
143.57
-6.31
(-4.21%)
USD |
NASDAQ |
Mar 05, 16:00
143.00
-0.57
(-0.40%)
After-Hours: 20:00
Insmed Free Cash Flow : -997.58M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Alnylam Pharmaceuticals, Inc. | 465.38M |
| Biogen, Inc. | 1.969B |
| Madrigal Pharmaceuticals, Inc. | -193.02M |
| ACADIA Pharmaceuticals, Inc. | 6.308M |
| CorMedix, Inc. | 74.42M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -247.60M |
| Cash from Investing (Quarterly) | 389.41M |
| Cash from Financing (Quarterly) | 33.86M |
| Free Cash Flow Per Share (Quarterly) | -1.377 |
| Free Cash Flow to Equity (Quarterly) | -305.09M |
| Free Cash Flow to Firm (Quarterly) | -273.49M |
| Free Cash Flow Yield | -3.49% |